Wuhan Keqian Biology Co.,Ltd (SHA:688526)
China flag China · Delayed Price · Currency is CNY
14.78
-0.25 (-1.66%)
May 12, 2026, 3:00 PM CST

SHA:688526 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
918935.65933.041,027974.141,083
Other Revenue
14.0914.098.8837.1427.1219.86
932.09949.74941.921,0641,0011,103
Revenue Growth (YoY)
-5.10%0.83%-11.48%6.27%-9.22%30.81%
Cost of Revenue
328.96330.72360.45321.43279.05230.42
Gross Profit
603.13619.03581.48742.65722.22872.6
Selling, General & Admin
154.26160.28169.4213.2219.26201.91
Research & Development
100.1896.4186.1288.51102.7580
Other Operating Expenses
-1.151.28-0.93-0.826.295.92
Operating Expenses
243.13247.8266.47385.36339.01296.9
Operating Income
360371.23315.01357.29383.21575.71
Interest Expense
---4.77-8.16-5.45-1.81
Interest & Investment Income
66.2663.8373.1794.1275.6971.86
Currency Exchange Gain (Loss)
-0.89-0.8900.05--
Other Non Operating Income (Expenses)
-21.191.15-0.72-0.21-0.2-0.27
EBT Excluding Unusual Items
404.18435.31382.69443.1453.25645.48
Impairment of Goodwill
---3.31---
Gain (Loss) on Sale of Investments
3133.2730.99-10.191.44-
Gain (Loss) on Sale of Assets
--0.93---
Asset Writedown
-3.27-1.28-0.86-1.72-0.14-1.57
Legal Settlements
-----0.82
Other Unusual Items
14.2414.2427.726.3912.0615.32
Pretax Income
446.15481.54438.13457.58466.61660.05
Income Tax Expense
58.3164.656.646257.4689.41
Earnings From Continuing Operations
387.84416.94381.49395.58409.15570.64
Minority Interest in Earnings
1.881.780.860.350.370.11
Net Income
389.72418.72382.35395.93409.52570.74
Net Income to Common
389.72418.72382.35395.93409.52570.74
Net Income Growth
-3.38%9.51%-3.43%-3.32%-28.25%27.45%
Shares Outstanding (Basic)
464465466466465464
Shares Outstanding (Diluted)
464465466466465464
Shares Change (YoY)
0.29%-0.22%0.10%0.10%0.29%20.20%
EPS (Basic)
0.840.900.820.850.881.23
EPS (Diluted)
0.840.900.820.850.881.23
EPS Growth
-3.66%9.76%-3.53%-3.41%-28.46%6.03%
Free Cash Flow
259.74344.66285.74433.53320.86156.82
Free Cash Flow Per Share
0.560.740.610.930.690.34
Dividend Per Share
0.6400.6400.4300.4300.1900.190
Dividend Growth
48.84%48.84%-126.32%--34.48%
Gross Margin
64.71%65.18%61.73%69.79%72.13%79.11%
Operating Margin
38.62%39.09%33.44%33.58%38.27%52.19%
Profit Margin
41.81%44.09%40.59%37.21%40.90%51.74%
Free Cash Flow Margin
27.87%36.29%30.34%40.74%32.05%14.22%
EBITDA
472.65482.99423.23470.54480.16638.35
EBITDA Margin
50.71%50.85%44.93%44.22%47.95%57.87%
D&A For EBITDA
112.65111.76108.22113.2496.9562.64
EBIT
360371.23315.01357.29383.21575.71
EBIT Margin
38.62%39.09%33.44%33.58%38.27%52.19%
Effective Tax Rate
13.07%13.41%12.93%13.55%12.31%13.55%
Revenue as Reported
949.74949.74941.921,0641,0011,103
Advertising Expenses
-25.4625.734.12.872.96
Source: S&P Global Market Intelligence. Standard template. Financial Sources.